Literature DB >> 24561619

Role of the SIK2-p35-PJA2 complex in pancreatic β-cell functional compensation.

Jun-Ichi Sakamaki, Accalia Fu, Courtney Reeks, Stephen Baird, Chantal Depatie, Mufida Al Azzabi, Nabeel Bardeesy, Anne-Claude Gingras, Siu-Pok Yee, Robert A Screaton.   

Abstract

Energy sensing by the AMP-activated protein kinase (AMPK) is of fundamental importance in cell biology. In the pancreatic β-cell, AMPK is a central regulator of insulin secretion. The capacity of the β-cell to increase insulin output is a critical compensatory mechanism in prediabetes, yet its molecular underpinnings are unclear. Here we delineate a complex consisting of the AMPK-related kinase SIK2, the CDK5 activator CDK5R1 (also known as p35) and the E3 ligase PJA2 essential for β-cell functional compensation. Following glucose stimulation, SIK2 phosphorylates p35 at Ser 91, to trigger its ubiquitylation by PJA2 and promote insulin secretion. Furthermore, SIK2 accumulates in β-cells in models of metabolic syndrome to permit compensatory secretion; in contrast, β-cell knockout of SIK2 leads to accumulation of p35 and impaired secretion. This work demonstrates that the SIK2-p35-PJA2 complex is essential for glucose homeostasis and provides a link between p35-CDK5 and the AMPK family in excitable cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24561619      PMCID: PMC4107453          DOI: 10.1038/ncb2919

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  51 in total

1.  Amplification at 11q23 targets protein kinase SIK2 in diffuse large B-cell lymphoma.

Authors:  Stefan Nagel; Ellen Leich; Hilmar Quentmeier; Corinna Meyer; Maren Kaufmann; Margarete Zaborski; Andreas Rosenwald; Hans G Drexler; Roderick A F Macleod
Journal:  Leuk Lymphoma       Date:  2010-05

2.  Failure of islet β-cell compensation for insulin resistance causes type 2 diabetes: what causes non-alcoholic fatty liver disease and non-alcoholic steatohepatitis?

Authors:  Christopher J Nolan
Journal:  J Gastroenterol Hepatol       Date:  2010-10       Impact factor: 4.029

3.  Loss of Lkb1 in adult beta cells increases beta cell mass and enhances glucose tolerance in mice.

Authors:  Accalia Fu; Andy Cheuk-Him Ng; Chantal Depatie; Nadeeja Wijesekara; Ying He; Gen-Sheng Wang; Nabeel Bardeesy; Fraser W Scott; Rhian M Touyz; Michael B Wheeler; Robert A Screaton
Journal:  Cell Metab       Date:  2009-10       Impact factor: 27.287

4.  Downregulation of SIK2 expression promotes the melanogenic program in mice.

Authors:  Nanao Horike; Ayako Kumagai; Yuko Shimono; Tomoko Onishi; Yumi Itoh; Tsutomu Sasaki; Kazuo Kitagawa; Osamu Hatano; Hiroaki Takagi; Teruo Susumu; Hiroshi Teraoka; Ken-ichi Kusano; Yasuo Nagaoka; Hidehisa Kawahara; Hiroshi Takemori
Journal:  Pigment Cell Melanoma Res       Date:  2010-08-31       Impact factor: 4.693

5.  SIK2 is a key regulator for neuronal survival after ischemia via TORC1-CREB.

Authors:  Tsutomu Sasaki; Hiroshi Takemori; Yoshiki Yagita; Yasukazu Terasaki; Tatsuya Uebi; Nanao Horike; Hiroaki Takagi; Teruo Susumu; Hiroshi Teraoka; Ken-Ichi Kusano; Osamu Hatano; Naoki Oyama; Yukio Sugiyama; Saburo Sakoda; Kazuo Kitagawa
Journal:  Neuron       Date:  2011-01-13       Impact factor: 17.173

6.  Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance.

Authors:  A Mari; A Tura; A Natali; M Laville; M Laakso; R Gabriel; H Beck-Nielsen; E Ferrannini
Journal:  Diabetologia       Date:  2010-01-09       Impact factor: 10.122

7.  SIK2 is a centrosome kinase required for bipolar mitotic spindle formation that provides a potential target for therapy in ovarian cancer.

Authors:  Ahmed Ashour Ahmed; Zhen Lu; Nicholas B Jennings; Dariush Etemadmoghadam; Luisa Capalbo; Rodrigo O Jacamo; Nuno Barbosa-Morais; Xiao-Feng Le; Pablo Vivas-Mejia; Gabriel Lopez-Berestein; Geoffrey Grandjean; Geoffrey Bartholomeusz; Warren Liao; Michael Andreeff; David Bowtell; David M Glover; Anil K Sood; Robert C Bast
Journal:  Cancer Cell       Date:  2010-08-09       Impact factor: 31.743

8.  Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice.

Authors:  Julien Bricambert; Jonatan Miranda; Fadila Benhamed; Jean Girard; Catherine Postic; Renaud Dentin
Journal:  J Clin Invest       Date:  2010-11-15       Impact factor: 14.808

9.  LKB1 deletion with the RIP2.Cre transgene modifies pancreatic beta-cell morphology and enhances insulin secretion in vivo.

Authors:  Gao Sun; Andrei I Tarasov; James A McGinty; Paul M French; Angela McDonald; Isabelle Leclerc; Guy A Rutter
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-03-30       Impact factor: 4.310

10.  LKB1 regulates pancreatic beta cell size, polarity, and function.

Authors:  Zvi Granot; Avital Swisa; Judith Magenheim; Miri Stolovich-Rain; Wakako Fujimoto; Elisabetta Manduchi; Takashi Miki; Jochen K Lennerz; Christian J Stoeckert; Oded Meyuhas; Susumu Seino; M Alan Permutt; Helen Piwnica-Worms; Nabeel Bardeesy; Yuval Dor
Journal:  Cell Metab       Date:  2009-10       Impact factor: 27.287

View more
  36 in total

1.  LKB1 couples glucose metabolism to insulin secretion in mice.

Authors:  Accalia Fu; Karine Robitaille; Brandon Faubert; Courtney Reeks; Xiao-Qing Dai; Alexandre B Hardy; Krishana S Sankar; Svetlana Ogrel; Osama Y Al-Dirbashi; Jonathan V Rocheleau; Michael B Wheeler; Patrick E MacDonald; Russell Jones; Robert A Screaton
Journal:  Diabetologia       Date:  2015-04-16       Impact factor: 10.122

2.  Salt-inducible Kinase 3 Signaling Is Important for the Gluconeogenic Programs in Mouse Hepatocytes.

Authors:  Yumi Itoh; Masato Sanosaka; Hiroyuki Fuchino; Yasuhito Yahara; Ayako Kumagai; Daisaku Takemoto; Mai Kagawa; Junko Doi; Miho Ohta; Noriyuki Tsumaki; Nobuo Kawahara; Hiroshi Takemori
Journal:  J Biol Chem       Date:  2015-06-05       Impact factor: 5.157

Review 3.  Salt-Inducible Kinases: Physiology, Regulation by cAMP, and Therapeutic Potential.

Authors:  Marc N Wein; Marc Foretz; David E Fisher; Ramnik J Xavier; Henry M Kronenberg
Journal:  Trends Endocrinol Metab       Date:  2018-08-24       Impact factor: 12.015

4.  The PTH/PTHrP-SIK3 pathway affects skeletogenesis through altered mTOR signaling.

Authors:  Fabiana Csukasi; Ivan Duran; Maya Barad; Tomas Barta; Iva Gudernova; Lukas Trantirek; Jorge H Martin; Caroline Y Kuo; Jeremy Woods; Hane Lee; Daniel H Cohn; Pavel Krejci; Deborah Krakow
Journal:  Sci Transl Med       Date:  2018-09-19       Impact factor: 17.956

5.  The AMPK-Related Kinases SIK1 and SIK3 Mediate Key Tumor-Suppressive Effects of LKB1 in NSCLC.

Authors:  Pablo E Hollstein; Lillian J Eichner; Sonja N Brun; Anwesh Kamireddy; Robert U Svensson; Liliana I Vera; Debbie S Ross; T J Rymoff; Amanda Hutchins; Hector M Galvez; April E Williams; Maxim N Shokhirev; Robert A Screaton; Rebecca Berdeaux; Reuben J Shaw
Journal:  Cancer Discov       Date:  2019-07-26       Impact factor: 39.397

Review 6.  Mechanisms of the amplifying pathway of insulin secretion in the β cell.

Authors:  Michael A Kalwat; Melanie H Cobb
Journal:  Pharmacol Ther       Date:  2017-05-18       Impact factor: 12.310

7.  The prolyl isomerase Pin1 increases β-cell proliferation and enhances insulin secretion.

Authors:  Yusuke Nakatsu; Keiichi Mori; Yasuka Matsunaga; Takeshi Yamamotoya; Koji Ueda; Yuki Inoue; Keiko Mitsuzaki-Miyoshi; Hideyuki Sakoda; Midori Fujishiro; Suguru Yamaguchi; Akifumi Kushiyama; Hiraku Ono; Hisamitsu Ishihara; Tomoichiro Asano
Journal:  J Biol Chem       Date:  2017-05-31       Impact factor: 5.157

8.  SIK2 regulates insulin secretion.

Authors:  Bengt-Frederik Belgardt; Markus Stoffel
Journal:  Nat Cell Biol       Date:  2014-03       Impact factor: 28.824

9.  High-throughput Functional Genomics Identifies Regulators of Primary Human Beta Cell Proliferation.

Authors:  Karine Robitaille; Jillian L Rourke; Joanne E McBane; Accalia Fu; Stephen Baird; Qiujiang Du; Tatsuya Kin; A M James Shapiro; Robert A Screaton
Journal:  J Biol Chem       Date:  2016-01-06       Impact factor: 5.157

10.  Two Degradation Pathways of the p35 Cdk5 (Cyclin-dependent Kinase) Activation Subunit, Dependent and Independent of Ubiquitination.

Authors:  Toshiyuki Takasugi; Seiji Minegishi; Akiko Asada; Taro Saito; Hiroyuki Kawahara; Shin-ichi Hisanaga
Journal:  J Biol Chem       Date:  2015-12-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.